US Patent Issued to TLC BIOPHARMACEUTICALS, TAIWAN LIPOSOME on April 14 for "Liposomal sustained-release compositions containing a therapeutic drug and use thereof" (Taiwanese Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,557, issued on April 14, was assigned to TLC BIOPHARMACEUTICALS INC. (South San Francisco, Calif.) and TAIWAN LIPOSOME Co. LTD. (Taipei City, Taiwan).

"Liposomal sustained-release compositions containing a therapeutic drug and use thereof" was invented by Yun-Long Tseng (Taipei, Taiwan) and Hsin-Yi Chiu (Taipei, Taiwan).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a liposomal sustained-release composition comprising a therapeutic agent and one or more lipids. The therapeutic agent and total lipids are present in the liposomal sustained-released composition at a predetermined ratio. The liposomal sustained-release composition achieves a...